Delivery Order SPE2DB20D7059-SPE2DB25FGRR9
- Not listed
- The Defense Logistics Agency (DLA) awarded a $3,449.50 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on September 12, 2025, with completion scheduled for September 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger federal contract vehicle. The order will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $4,936.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of September 2, 2025. This is an unset-aside, competitively awarded contract with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes in 0.5 ML quantities, with a contract ceiling value of $6,899.00. This is a firm fixed-price delivery order with an ultimate completion date of September 5, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $6,899.00, with completion due by August 1, 2025. This non-set-aside, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a $13,645.30 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitively awarded, firm fixed-price contract is scheduled for completion by July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- AmerisourceBergen Drug Corp received a delivery order valued at $47,613.71 from the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This firm fixed-price delivery order, with an ultimate completion date of August 12, 2025, represents a competitively awarded contract with no set-aside designation. The vaccine product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $26,061.50 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This is a firm fixed price, competitively awarded contract with an ultimate completion date of August 20, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes valued at $10,348.50 under a firm fixed-price contract. This non-competitive delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.99 million through December 2026. The delivery location is AmerisourceBergen's corporate office in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $76,849.21 by the Defense Logistics Agency on September 3, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes (0.5 ML). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 4, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child contract executed...
- The Defense Logistics Agency awarded a $55,192 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FGRR9Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 13, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes valued at $10,448.50 with a firm fixed price contract type. The award is non-set-aside and carries an ultimate completion date of September 15, 2025. Performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant role in the federal medical supply chain through its comprehensive IDC with DLA. The company's contract portfolio demonstrates extensive capability in supplying pharmaceutical products and medical commodities to support military and veteran healthcare systems, including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for TYPHIM VI vaccine syringes exemplifies the company's role as a critical vendor fulfilling federal medical procurement needs through competitively awarded contracts with firm fixed pricing structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 9/13/25 |